capital_markets

XTEND Debuts on NYSE as AT&T Marks 125 Years Listed

Image
XTEND Debuts on NYSE as AT&T Marks 125 Years Listed

New York – September 08, 2026 -- XTEND, an AI-powered defense robotics and software company, will begin trading on the New York Stock Exchange under the ticker symbol XTND following a business combination with JFB Construction Holdings.

XTEND merges with JFB Construction Holdings to form XTEND AI Robotics

The combined entity will operate under the new name XTEND AI Robotics once the transaction closes. XTEND CEO Aviv Shapira said the listing marks the next chapter in the company's growth.

AT&T marks 125 years as an NYSE-listed company

AT&T (NYSE: T) is observing the 125th anniversary of its NYSE listing, having first traded on the exchange on this date in 1901. The telecommunications carrier ranks as the 11th-longest continuously listed company on the NYSE. Brett Feldman, AT&T's Senior Vice President, Treasurer and Head of Investor Relations, is scheduled to discuss the milestone on NYSE's Taking Stock program later today.

Cango Regains NYSE Compliance After 10-for-1 Share Consolidation

Image
Cango Regains NYSE Compliance After 10-for-1 Share Consolidation

Dallas – September 08, 2026 -- Cango Inc. (NYSE: CANG) has regained compliance with the New York Stock Exchange's minimum share price requirement, the company said, closing a listing-standards issue that began in March.

NYSE confirms Cango cleared the $1.00 threshold as of August 31, 2026

In a letter dated September 1, 2026, the NYSE notified Cango that its average closing share price over the 30 trading days ended August 31, 2026 exceeded the exchange's US$1.00 minimum under Section 802.01C of the NYSE Listed Company Manual. The exchange confirmed the matter is now closed.

Company had received a deficiency notice on March 10, 2026

The NYSE had flagged Cango after its Class A ordinary shares' 30-trading-day average closing price fell below $1.00, triggering a formal compliance notification.

Insilico Medicine Joins HKEX Tech 100 Index Amid Record AI Drug Pipeline

Cambridge – September 07, 2026 -- Insilico Medicine (HKEX: 3696) will join the HKEX Tech 100 Index effective September 14, 2026, following methodology changes announced August 18, 2026, that widen the benchmark's exposure to the AI value chain. Index changes take effect after market close on September 11, 2026 (Friday).

HKEX Tech 100 Index tracks 100 leading Hong Kong tech names across six themes

The index measures 100 of the largest Hong Kong-listed companies with high exposure to technology themes eligible for Southbound Stock Connect. It spans artificial intelligence, biotech and pharmaceutical, electric vehicles and smart driving, information technology, internet, and robotics.

Scage Future Falls Below Nasdaq's $50M Market Value Threshold

Nanjing – September 07, 2026 -- Scage Future (Nasdaq: SCAG) has fallen below two separate Nasdaq minimum listing thresholds, receiving deficiency notices tied to both its total market value of listed securities and its market value of publicly held shares.

Nasdaq flags dual shortfalls in 30-day trading review

The Listing Qualifications Department of The Nasdaq Stock Market sent two notification letters dated August 27, 2026. Based on the 30 consecutive business days from July 16 to August 26, 2026, Scage's Market Value of Listed Securities (MVLS) fell short of the required US$50,000,000 minimum under Rule 5450(b)(2)(A). Nasdaq also noted the company fails the alternative Total Assets and Total Revenue standard under Rule 5450(b)(3)(A). A second letter cited the company's Market Value of Publicly Held Shares (MVPHS) falling below the required US$15,000,000 minimum under Rule 5450(b)(2&3)(C) over the same period.

Three Lions Acquisition Closes $100M IPO, Eyes Sports Deals

New York – September 07, 2026 -- Three Lions Acquisition Corp. closed its initial public offering of 10,000,000 units, generating $100,000,000 in gross proceeds, the special purpose acquisition company announced. A total of $100,500,000 from the IPO and a simultaneous private placement was placed in trust.

Units priced at $10.00 begin trading on Nasdaq under ticker TLACU

Each unit consists of one ordinary share and one-half of one warrant, with each whole warrant exercisable at $11.50 per share. Once components separate, the ordinary shares and warrants are expected to list on Nasdaq under the symbols TLAC and TLACW, respectively.

IRG, PREP Funds Acquire 339,449 Sq Ft Anchor Manufacturing Portfolio

Cleveland – September 07, 2026 -- Industrial Realty Group (IRG), PREP Funds and CG Real Estate Capital have closed a sale-leaseback transaction with Anchor Manufacturing, acquiring a three-property industrial portfolio totaling 339,449 square feet on 18.44 acres in Cleveland, Ohio.

Anchor Manufacturing signs long-term master lease to remain at all three sites

Under the deal, Anchor Manufacturing has entered a long-term master lease and will continue operating its headquarters and manufacturing facilities across each property, preserving its full operational footprint in Cleveland while monetizing the underlying real estate.

Kazia Therapeutics Closes Oversubscribed Offering, Up to $120M Raised

Image
Kazia Therapeutics Closes Oversubscribed Offering, Up to $120M Raised

Sydney – September 04, 2026 -- Kazia Therapeutics Limited (NASDAQ: KZIA) has closed an oversubscribed, tranched public offering that generated approximately $40 million in upfront gross proceeds, with total potential proceeds reaching approximately $120 million if milestone-linked warrants are fully exercised.

Offering priced above market with milestone-triggered warrant premiums

The combined offering price was set at $15.50 per American Depositary Share (ADS), with both warrant tranches priced at premiums to that level. Series A Warrants carry an exercise price of $17.825 per ADS, a 15% premium, tied to Kazia's Stage IV triple-negative breast cancer (TNBC) data readout expected in the second half of 2027. Series B Warrants carry an exercise price of $19.375 per ADS, a 25% premium, tied to the company's HR+/HER2- breast cancer data readout expected in the first half of 2028.

Phoenix Tower Locks $6.5B Financing Across 23 Jurisdictions

Image
Phoenix Tower Locks $6.5B Financing Across 23 Jurisdictions

BOCA RATON, Fla. -- September 01, 2026 -- Phoenix Tower International (PTI) has signed a $6.5 billion multi-jurisdiction financing package, the largest such deal for a privately held tower company in the wireless infrastructure sector.

Ericsson Buys Back 2.15 Million Shares for SEK 208 Million in Late August

STOCKHOLM -- September 01, 2026 -- Telefonaktiebolaget LM Ericsson repurchased 2,150,000 Class B shares for SEK 208,051,855 during the week of August 24-28, 2026, according to a filing released August 31. Goldman Sachs Bank Europe SE executed the trades on Nasdaq Stockholm on Ericsson's behalf. The purchases form part of a buyback program of up to SEK 15,000,000,000 that Ericsson launched on April 16, 2026, running through March 31, 2027.